Full-Time

Logistics Operator 2

Nemera

Nemera

1,001-5,000 employees

Designs, develops, manufactures drug delivery devices

No salary listed

Wheeling, IL, USA

In Person

Category
Operations & Logistics (2)
,
Requirements
  • High School Diploma, GED, or equivalent.
  • Ability to read/write/speak English.
  • Able to lift up to 55 lbs.
Responsibilities
  • Follow all safety procedures, including the use of PPE as required.
  • Package, Label, and stack product on skids per Lot information and product specification.
  • Report any out of line conditions, damaged equipment to Supervisor or maintenance.
  • Retrieve packing material from warehouse.
  • Support and maintain all policies of the company including but not limited to Health and Safety Requirements, GMP and standard work procedures, Continuous Improvement & ISO Standards.
  • Maintain clean workspace and 5S Standards in work area.
  • Operate packaging equipment as required per product specifications and/or work instructions.
  • Complete Packaging auxiliary equipment (TPM) Total Productive Maintenance activities as needed.
  • Follow instructions as required per ID sheets and visuals.
  • Maintain Lean initiatives and participate in lean projects.
  • Provide suggestions and take active role in Process Improvements to eliminate non-value-added activity.
  • Perform line clearances as required.
  • Other duties as assigned.
Desired Qualifications
  • High School Diploma or equivalent.
  • Basic math skills.
  • Computer skills including Microsoft Office applications.

Nemera designs, develops, and manufactures drug delivery devices for pharmaceutical and biotech companies, spanning ophthalmic, nasal, buccal, parenteral, dermal, and inhalation routes. The devices are used to administer medicines and are developed and manufactured in collaboration with customers, often through co-development and customized production in a B2B model. It stands out by offering an end-to-end range of delivery solutions across multiple administration routes, supported by global manufacturing facilities and a wide distribution network. Its goal is to enable safer, more convenient self-administered therapies by providing scalable devices and related design and manufacturing services to partners.

Company Size

1,001-5,000

Company Stage

Acquired

Total Funding

$1.2B

Headquarters

La Verpillière, France

Founded

2014

Simplify Jobs

Simplify's Take

What believers are saying

  • Rising demand for diabetes and obesity injection pens drives La Verpillière expansion, starting production 2027.
  • New Szczecin hall strengthens leadership in GLP-1 drug market for obesity therapies.
  • Milfra acquisition in June 2021 expands footprint in Brazil's gynecology and urology markets.

What critics are saying

  • SteadyMed's Releev One captures Symbioze market share in GLP-1 delivery within 12-18 months.
  • Ypsomed's dose accuracy wins Novo Nordisk contracts, undercutting La Verpillière capacity in 6-12 months.
  • SHL Medical's DAI platform displaces Nemera's devices in Eli Lilly obesity pens within 12-24 months.

What makes Nemera unique

  • Nemera specializes in drug delivery devices across ophthalmic, nasal, buccal, parenteral, dermal, and inhalation routes.
  • Launched Symbioze wearable injector in October 2021 for self-administration needs.
  • Introduced UniSpray unidose nasal system for emergency systemic drug delivery.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Company News

Nemera
Jul 21st, 2025
Nemera expands production capacity in Szczecin to strengthen leadership in GLP-1 drug market

Nemera, a global leader in the design, development, and manufacturing of drug delivery device solutions, has inaugurated a new production hall at its state-of-the-art facility in Szczecin, Poland.

Nemera
Oct 11th, 2023
Nemera extends manufacturing capabilities in North America

That's the new space Nemera has acquired to set up the next state-of-the-art manufacturing facility.

Jobmatch Ohio
Sep 15th, 2023
Printer Operator- Off Shift

In May of 2014, Rexam sold the plastics business and the Berlin Plant was acquired by Nemera, naming the prescription products business as Centor Inc.

The Real Deal
Jul 25th, 2023
Panattoni gets $26M for Vernon Hills industrial building

French medical device manufacturer Nemera is expanding its industrial footprint in suburban Chicago.

Nemera
Mar 10th, 2023
Nemera reinforces commitment to sustainability with first integrated ESG report

Nemera France SAS is thrilled to announce the publication of its first integrated ESG report.